Logo image of CCM

CONCORD MEDICAL - SPON ADR (CCM) Stock Fundamental Analysis

NYSE:CCM - New York Stock Exchange, Inc. - US2062772049 - ADR - Currency: USD

5.25  -0.25 (-4.55%)

Fundamental Rating

0

Overall CCM gets a fundamental rating of 0 out of 10. We evaluated CCM against 103 industry peers in the Health Care Providers & Services industry. CCM has a bad profitability rating. Also its financial health evaluation is rather negative. CCM has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CCM had negative earnings in the past year.
CCM had a negative operating cash flow in the past year.
In the past 5 years CCM always reported negative net income.
In the past 5 years CCM always reported negative operating cash flow.
CCM Yearly Net Income VS EBIT VS OCF VS FCFCCM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

CCM's Return On Assets of -4.58% is on the low side compared to the rest of the industry. CCM is outperformed by 67.96% of its industry peers.
Industry RankSector Rank
ROA -4.58%
ROE N/A
ROIC N/A
ROA(3y)-5.89%
ROA(5y)-5.56%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CCM Yearly ROA, ROE, ROICCCM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CCM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CCM Yearly Profit, Operating, Gross MarginsCCM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

More info and screens

0

2. Health

2.1 Basic Checks

CCM does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CCM remains at a similar level compared to 1 year ago.
The number of shares outstanding for CCM remains at a similar level compared to 5 years ago.
Compared to 1 year ago, CCM has a worse debt to assets ratio.
CCM Yearly Shares OutstandingCCM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CCM Yearly Total Debt VS Total AssetsCCM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of -1.20, we must say that CCM is in the distress zone and has some risk of bankruptcy.
CCM has a worse Altman-Z score (-1.20) than 84.47% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.2
ROIC/WACCN/A
WACC5.03%
CCM Yearly LT Debt VS Equity VS FCFCCM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B -2B

2.3 Liquidity

A Current Ratio of 0.46 indicates that CCM may have some problems paying its short term obligations.
CCM's Current ratio of 0.46 is on the low side compared to the rest of the industry. CCM is outperformed by 91.26% of its industry peers.
A Quick Ratio of 0.45 indicates that CCM may have some problems paying its short term obligations.
The Quick ratio of CCM (0.45) is worse than 90.29% of its industry peers.
Industry RankSector Rank
Current Ratio 0.46
Quick Ratio 0.45
CCM Yearly Current Assets VS Current LiabilitesCCM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

2

3. Growth

3.1 Past

CCM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 72.61%, which is quite impressive.
The Revenue for CCM has decreased by -28.56% in the past year. This is quite bad
CCM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.12% yearly.
EPS 1Y (TTM)72.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%34.18%
Revenue 1Y (TTM)-28.56%
Revenue growth 3Y-7.53%
Revenue growth 5Y14.12%
Sales Q2Q%-34.78%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CCM Yearly Revenue VS EstimatesCCM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
CCM Yearly EPS VS EstimatesCCM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 0 2 -2 4 -4 -6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CCM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CCM Price Earnings VS Forward Price EarningsCCM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CCM Per share dataCCM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6 -8 -10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CCM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CONCORD MEDICAL - SPON ADR

NYSE:CCM (7/11/2025, 8:04:00 PM)

5.25

-0.25 (-4.55%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-15 2024-10-15
Earnings (Next)N/A N/A
Inst Owners0.02%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap227.94M
Analysts42.5
Price TargetN/A
Short Float %0.02%
Short Ratio0.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.26
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.99
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.79
FCFYN/A
OCF(TTM)-1.28
OCFYN/A
SpS1.23
BVpS-7.32
TBVpS-10.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.58%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-5.89%
ROA(5y)-5.56%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 189.41%
Cap/Sales 41.93%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.46
Quick Ratio 0.45
Altman-Z -1.2
F-Score2
WACC5.03%
ROIC/WACCN/A
Cap/Depr(3y)166.87%
Cap/Depr(5y)201.39%
Cap/Sales(3y)37.04%
Cap/Sales(5y)50.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)72.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%34.18%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-28.56%
Revenue growth 3Y-7.53%
Revenue growth 5Y14.12%
Sales Q2Q%-34.78%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-14.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-42.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-44.2%
OCF growth 3YN/A
OCF growth 5YN/A